Skip to main content
. 2010 Jun 20;67(4):829–835. doi: 10.1007/s00280-010-1384-z

Table 3.

Association between TFI and effectiveness of second-line chemotherapy

CR/PR SD/PD
TFI ≥ 6 months 10 (42%)a 14 (58%)
TFI < 6 months 0 (0%) 16 (100%)a

Forty-two percent (10 out of 24 cases) of the patients whose TFI was equal to or longer than 6 months exhibited sensitivity to second-line chemotherapy; however, all cases whose TFI was shorter than 6 months were resistant to second-line chemotherapy. This association was statistically significant (P = 0.0026 by Fisher’s exact test)

TFI treatment-free interval, CR complete response, PR partial response, SD stable disease, PD progressive disease

a P = 0.0026